| Literature DB >> 24759685 |
Chien-Cheng Jung1, Hsiu-Hao Liang1, Hui-Ling Lee2, Nai-Yun Hsu1, Huey-Jen Su1.
Abstract
This study investigates whether indoor environmental quality (IEQ) influences allostatic load (AL) and whether AL can be a predictor for sick building syndrome (SBS). We also assessed and compared the associations between AL and SBS versus 8-hydroxydeoxyguanosine (8-OHdG) and SBS. A total of 115 office workers from 21 offices completed self-reported SBS questionnaires, and provided 11 biomarkers for their AL. Multiple linear regressions and logistic regression analysis were applied to examine the correlations between IEQ and AL or 8-OHdG and between AL or 8-OHdG and SBS, respectively. Our data revealed that the neuroendocrine system was correlated with CO2, the difference between indoor and outdoor CO2 levels (dCO2), and the indoor-outdoor ratio of CO2 (CO2 I/O). Metabolic system effects were associated with illumination. The relationships between illumination, CO2, dCO2, CO2 I/O and 8-OHdG were consistent with those and AL in specific systems. Furthermore, we found that risks for SBS syndromes were related with neuroendocrine and metabolic system of the AL. 8-OHdG was associated with eye dryness or irritation, eye tiredness and vomiting. We conclude that IEQ significantly influences AL and that AL can be a predictor for reporting SBS with information on system-specific effects.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24759685 PMCID: PMC3997416 DOI: 10.1371/journal.pone.0095791
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary statistics for characteristics of subjects.
| Variables | Mean ±S.D. or n (%) |
| Age (years) | 34.2±5.7 |
| Males | 83 (72.2%) |
| Working years | 4.4±4.3 |
| Weekly working hours | 42.5±14.2 |
| Education (years) | |
| ≤12 (High school) | 3 (2.6%) |
| 13–16 (College) | 66 (57.4%) |
| ≥17 (Master or higher) | 46 (40.0%) |
| Monthly income (NTD) | |
| <20,000 | 2 (0.9%) |
| 20,000–40,000 | 36 (31.3%) |
| 40,000–60,000 | 28 (24.3%) |
| 60,000–80,000 | 29 (25.2%) |
| 80,000–100,000 | 8 (7.0%) |
| ≥100,000 | 12 (10.4%) |
| Marital status (n, %) | |
| Unmarried or single | 59 (51.3%) |
| Married or live together | 54 (47.0%) |
| Others | 2 (1.7%) |
| Smoking behavior (n, %) | |
| Non-smoker | 99 (86.1%) |
| Smoker | 16 (13.9%) |
| Exercise frequency (≥45 min per week. n, %)** | |
| Always | 5 (4.5%) |
| Usually | |
| Often | 16 (14.5%) |
| Sometime | 57 (51.4%) |
| Never | 11 (9.9%) |
S.D. Standard deviation NTD: New Taiwanese Dollars.
*Missing 1 samples **Missing 4 samples.
Cutoff for each biomarker of allostatic load.
| Biomarkers | Cutoff point |
| BMI (kg/m2) | ≥26.8 |
| Fat (%) | ≥29.4 |
| SBP (mmHg) | ≥132.5 |
| DBP (mmHg) | ≥86.5 |
| Heart rate (times/min) | ≥83.0 |
| IL-6 (pg/ml) | ≥15.4 |
| TNF-α (pg/ml) | ≥10.7 |
| Cortisol (µg/g creatinine) | ≥20.8 |
| Epinephrine (µg/g creatinine) | ≥17.7 |
| Norepinephrine (µg/g creatinine) | ≥42.9 |
| Creatinine (mg/dl) | ≥109.3 |
AL score and 8-OHdG level.
| Biomarkers | Mean ±S.D. | Median | Min-Max |
| AL scores | |||
| Cardio. and Resp. system | 0.8±0.9 | 0 | 0–3 |
| Anthropometric system | 0.5±0.8 | 0 | 0–2 |
| Neuroendocrine system | 0.7±0.8 | 1 | 0–3 |
| Immune system | 0.4±0.7 | 0 | 0–2 |
| Metabolic system | 0.3±0.4 | 0 | 0–1 |
| Total allostatic scores | 2.6±1.7 | 2 | 0–7 |
| 8-OHdG (mg/g creatinine) | 4.1±2.2 | 3.5 | 0.8–12.9 |
S.D. Standard deviation.
Cardio. and Resp. (Cardiovascular and respiratory).
Prevalence of SBS in males and females.
| Symptoms | All (%, n) | Male (%, n) | Female (%, n) |
|
| Eye dryness or irritation | 35.7 (41) | 28.9 (24) | 53.1 (17) | <0.05 |
| Stridor | 2.6 (3) | 1.2 (1) | 6.3 (2) | 0.18 |
| Headache | 29.6 (34) | 26.5 (22) | 37.5 (12) | 0.25 |
| Dry throat | 27.8 (32) | 19.3 (16) | 50.0 (16) | <0.05 |
| Tiredness | 27.8 (31) | 26.5 (22) | 28.1 (9) | 0.81 |
| Chest discomfort | 13.9 (16) | 10.8 (9) | 21.9 (7) | 0.14 |
| Nose itch | 31.2 (37) | 27.7 (23) | 43.8 (14) | 0.12 |
| Cough | 36.5 (42) | 33.7 (28) | 43.8(14) | 0.439 |
| Eye tiredness | 63.5 (73) | 54.2 (45) | 87.5 (28) | <0.05 |
| Nervous feeling | 33.9 (39) | 30.1 (25) | 43.8 (14) | 0.19 |
| Pain in neck, shoulders or back | 55.7 (64) | 50.6 (42) | 68.8 (22) | 0.10 |
| Sneeze | 38.3 (44) | 28.9 (24) | 62.5 (20) | <0.05 |
| Concentration difficulty | 45.2 (52) | 38.6 (32) | 62.5 (20) | <0.05 |
| Dizziness | 23.5 (27) | 18.1 (15) | 37.5 (12) | <0.05 |
| Depression | 33.0 (38) | 24.1 (20) | 56.3 (18) | <0.05 |
| Breathing difficulty | 12.2 (14) | 8.4 (7) | 21.9 (7) | 0.06 |
| Vomit | 13.4 (15) | 7.2 (6) | 28.1 (9) | <0.05 |
| Skin dryness or itch | 26.1 (30) | 18.1 (15) | 46.9 (15) | <0.05 |
*Statistical significance at p<0.05.
Indoor environmental quality in 21 office units.
| Environmental indexes | Mean ±S.D. | Median | Range |
| Illumination (Lux) | 495.2±392.0 | 384.5 | 57.6–1485.0 |
| CO (ppm) | 0.73±0.10 | 0.74 | 0.54–0.90 |
| CO2 (ppm) | 742.0±212.3 | 664.2 | 464.0–1193.6 |
| TVOC (ppb) | 539.1±348.8 | 380.6 | 1.4–1330.0 |
| PM2.5 (µg/m3) | 37.9±31.3 | 27.3 | 6.1–126.5 |
| Total fungi (CFU/m3) | 507.2±751.5 | 254.4 | 115.0–3180.2 |
| Total bacterial (CFU/m3) | 385.2±222.4 | 333.3 | 123.7–927.3 |
| dCO2 (ppm) | 285.5±190.3 | 264.2 | 31.2–701.9 |
| CO2 I/O | 1.62±0.38 | 1.65 | 1.07–2.43 |
S.D. Standard deviation.
*Illumination was measured from each subject's desk.
CO, CO2 and TVOC missing 2, 2 and 1 samples, respectively.
β relating to indoor environmental quality, AL score and 8-OHdG level (Standard error).
| Environmental factors | Total AL score | System AL score | 8-OHdG | ||||
| Cardio. and Resp. | Anthropometric | Neuroendocrine | Immune | Metabolic | |||
| Illumination (Lux) | 0.000 (0.001) | 0.000 (0.000) | 0.000 (0.000) | 0.000 (0.000) | −0.000 (0.000) | −0.000 (0.000) | 0.002 (0.000) |
| CO2 (ppm) | 0.001 (0.001) | 0.001 (0.000) | −0.000 (0.000) | 0.001 (0.001) | −0.001 (0.000) | −0.000 (0.000) | 0.000 (0.000) |
| CO (ppm) | −0.515 (0.489) | −0.332 (0.248) | −0.065 (0.215) | −0.224 (0.234) | 0.487 (0.210) | −0.124 (0.123) | −0.636 (0.536) |
| TVOC (ppm) | −0.000 (0.001) | 0.000 (0.000) | −0.000 (0.000) | 0.000 (0.000) | −0.000 (0.000) | −0.000 (0.000) | −0.000 (0.001) |
| PM2.5 (µg/m3) | −0.014 (0.006) | −0.002 (0.003) | −0.002 (0.003) | −0.006 (0.003) | −0.005 (0.003) | −0.002 (0.002) | 0.006 (0.008) |
| Total bacteria (CFU/m3) | 0.000 (0.001) | −0.001 (0.000) | 0.001 (0.000) | 0.000 (0.000) | −0.000 (0.000) | −0.000 (0.000) | 0.002 (0.001) |
| Total fungi (CFU/m3) | −0.000 (0.000) | 0.000 (0.000) | −0.000 (0.000) | −0.000 (0.000) | −0.000 (0.000) | −0.000 (0.000) | 0.000 (0.000) |
| dCO2 (ppm) | 0.001 (0.001) | 0.001 (0.001) | −0.000 (0.000) | 0.001 (0.001) | −0.001 (0.001) | −0.000 (0.000) | 0.004 (0.001) |
| CO2 I/O ratio | 0.619 (0.592) | 0.348 (0.304) | 0.019 (0.260) | 0.561 (0.263) | −0.229 (0.255) | −0.278 (0.145) | 1.978 (0.621) |
Adjusted for age, gender, smoking behavior, education attainment, monthly income, marital status and exercise frequency.
*Statistical significance at p<0.05.
Odds ratio of SBS associated with AL scores and 8-OHdG level (Odds ratio 95% CI).
| Symptoms | Total AL score | System AL score | 8-OHdG | ||||
| Cardio. and Resp. | Anthropometric | Neuroendocrine | Immune | Metabolic | |||
| Eye dryness or irritation | 1.22(0.88–1.69) | 1.26(0.66–2.38) | 1.74(0.84–3.61) | 1.28(0.62–2.66) | 0.82(0.35–1.89) | 1.00(0.25–4.02) | 1.47(1.01–2.15) |
| Headache | 1.07(0.76–1.52) | 1.03(0.52–2.03) | 0.93(0.42–2.06) | 1.05(0.48–2.31) | 1.24(0.51–3.03) | 1.43(0.31–6.51) | 1.38(0.97–1.95) |
| Dry throat | 1.25(0.90–1.74) | 1.89(0.87–3.94) | 1.77(0.82–3.83) | 1.13(0.52–2.44) | 1.12(0.48–2.63) | 0.51(0.12–2.23) | 1.38(0.97–1.97) |
| Tiredness | 1.16(0.83–1.62) | 1.38(0.70–2.74) | 1.45(0.69–3.06) | 1.02(0.47–2.20) | 1.85(0.74–4.65) | 0.20(0.04–1.01) | 1.33(0.94–1.88) |
| Chest Discomfort | 1.21(0.75–1.96) | 1.06(0.41–2.77) | 0.62(0.20–1.94) | 1.95(0.73–5.23) | 1.45(0.48–4.34) | 4.84(0.47–50.30) | 1.33(0.85–2.07) |
| Nose itch | 0.82(0.58–1.16) | 0.41(0.16–1.06) | 0.57(0.24–1.32) | 1.96(0.89–4.31) | 0.68(0.25–1.84) | 0.72(0.14–3.71) | 1.39(0.97–1.97) |
| Cough | 1.13(0.84–1.53) | 0.97(0.51–1.85) | 0.95(0.46–1.95) | 3.31(1.36–8.06)** | 0.97(0.46–2.08) | 0.60(0.15–2.36) | 1.27(0.91–1.76) |
| Eye tiredness | 0.96(0.71–1.32) | 1.18(0.62–2.26) | 1.04(0.50–2.19) | 1.20(0.59–2.43) | 0.70(0.33–1.51) | 0.29(0.07–1.28) | 1.83(1.11–3.02) |
| Nervousness | 0.95(0.69–1.29) | 0.74(0.36–1.51) | 0.70(0.32–1.51) | 1.02(0.50–2.08) | 0.87(0.36–2.09) | 3.34(0.81–13.84) | 1.10(0.89–1.52) |
| Pain in neck, shoulders or back | 1.13(0.85–1.49) | 1.26(0.70–2.28) | 0.96(0.51–1.81) | 1.95(1.01–3.77) | 0.73(0.35–1.49) | 0.93 (0.26–3.38) | 1.07(0.79–1.46) |
| Sneeze | 0.66(0.44–0.96) | 0.34(0.13–0.91) | 0.83(0.38–1.79) | 1.22(0.55–2.73) | 0.37(0.12–1.12) | 0.18(0.03–1.05) | 1.19(0.82–1.71) |
| Concentration difficulty | 1.14(0.83–1.58) | 1.15(0.59–2.23) | 1.20(0.59–2.42) | 1.76(0.85–3.62) | 1.06 (0.48–2.32) | 0.31(0.07–1.42) | 1.45(0.96–2.19) |
| Dizziness | 0.94(0.65–1.37) | 0.57(0.24–1.36) | 0.98(0.39–2.45) | 1.39(0.57–3.41) | 1.60(0.50–5.11) | 0.64(0.13–3.32) | 1.41(0.95–2.10) |
| Depression | 1.16(0.82–1.64) | 0.83 (0.41–1.67) | 0.92(0.43–1.94) | 1.41(0.66–3.01) | 1.57(0.65–3.80) | 6.15(1.29–29.39) | 1.24(0.86–1.80) |
| Breathing difficulty | 0.86(0.46–1.61) | 0.52(0.12–2.36) | 0.76 (0.20–2.92) | 2.57(0.61–10.80) | 0.57(0.09–3.65) | – | 1.49(0.74–2.98) |
| Vomit | 0.90(0.59–1.37) | 0.41(0.11–1.57) | 0.36(0.10–1.24) | 2.34(0.75–7.29) | 1.38(0.45–4.23) | 0.88(0.13–6.25) | 1.91(1.11–3.27) |
| Skin dryness or itch | 1.36 (0.92–2.01) | 0.43(0.75–3.97) | 2.33 (0.90–6.06) | 1.84(0.76–4.49) | 0.64(0.22–1.86) | 0.94(0.18–4.97) | 1.01(0.71–1.45) |
Adjusted for age, gender, smoking behavior, education attainment, monthly income, marital status, exercise frequency, lux, CO, CO2, TVOC, PM2.5, bacteria, fungi, CO2 indoor and outdoor ratio, different of indoor and outdoor CO2.
*Statistical significance p<0.05 ** Statistical significance p<0.01.